NORRETT KEVIN (Chief Business Officer) received a stock award from SOLENO THERAPEUTICS INC
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 1/23/2026ACC: 0001819690-26-000002
Officer· Chief Business Officer
Since Nov 2025
+7.50K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
7.50K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+3.50K
Price / share
—
Trade value
—
% of position
24.5%
1/21/2026
14.29K→17.79K
Total
Net shares
+3.50K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/21/2026 | A · Award | +3.50K | — | — | 24.5% | 14.29K | 17.79K |
| Total | +3.50K | $0.00 | ||||||
Derivative Transactions1
Employee stock option (right to buy)
Direct
Converts to
Common Stock
4K shares
Shares
+4K
Strike price
43.65
Held after
4K
Exercisable
—
1/21/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Employee stock option (right to buy) Direct | Common Stock4K shares | 1/21/2026 | A · Award | +4K | 43.65 | — | 4K |